Health Biotech Limited, an Indian pharma company focused on research, participated successfully at CPHI Frankfurt 2025, a leading global pharmaceutical exhibition, held from October 28 to 30 in Germany.
Dr. Reddy's Laboratories (DRL) will probably take some time to release its generic injectable semaglutide in Canada after receiving the health regulatory body, Health Canada's Pharmaceutical Drugs Directorate, Notice of Non-Compliance (NoN).
The US Food and Drug Administration's (FDA) draft guidance aimed at speeding up and making less expensive biosimilar development is going to be a massive relief to Indian pharma and biotech companies.
German inks and coatings leader Siegwerk has introduced a new range of mineral oil-free inks to India's pharmaceutical packaging sector, thus making a major move towards safer and more compliant packaging solutions.
AskBio, a fully owned and independently operated subsidiary of Bayer AG, has shared positive 12-month data from its Phase 1 clinical trial of AB-1002, an experimental gene therapy for congestive heart failure (CHF).
India has increased its trade protection actions by broadening an anti-dumping probe concerning the import of Ethambutol Hydrochloride, which is a major one of the six essential active pharmaceutical ingredient
Novartis has formally closed its acquisition of Tourmaline Bio, a strategic step to advance its leadership in cardiovascular innovation. After the closing, common stock of Tourmaline, with each share having a par value of $0.0001, has ceased...
Granules India increased 2.04% to Rs 581.15 after it disclosed that it had received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its API Unit-I facility in Bonthapally, Hyderabad...
Max Healthcare, India’s one of the most populous hospital chains by revenue, will be funded entirely through internal accruals. Free cash flow of the company will be enough to support the expansion without raising debt
.jpeg){kind=spacer}
After the discovery of diethylene glycol (DEG) in some cough syrups, the Central Drugs Standard Control Organisation (CDSCO) has launched a digitally monitored system on the Online National Drug Licensing System (ONDLS) portal.
, CDSCO.jpg)